Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Jubilant Pharmova LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code:530019NSE Symbol: JUBLPHARMAP/E(TTM):0
ISIN Demat:INE700A01033Div & Yield %:0.43EPS(TTM):1.54
Book Value(Rs):145.519774Market Cap ( Cr.):18646.07Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
INCOME :      
Sales Turnover 784.70810.10725.732709.503139.903438.61
Excise Duty0.000.000.000.000.000.00
Net Sales784.70810.10725.732709.503139.903438.61
Other Income 103.40137.90126.1647.88173.2378.00
Stock Adjustments -39.00-3.5040.61-55.21108.32-46.74
Total Income849.10944.50892.502702.173421.453469.87
EXPENDITURE :      
Raw Materials 316.50411.10372.891395.151792.742006.07
Power & Fuel Cost68.4075.4062.31280.40369.20358.28
Employee Cost 190.00167.30163.64220.67264.90265.71
Other Manufacturing Expenses 59.6049.0039.80216.91269.07255.24
Selling and Administration Expenses 88.6093.00111.59100.02143.14138.82
Miscellaneous Expenses 6.107.709.6514.0739.9646.87
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure729.20803.50759.882227.232879.023070.99
Operating Profit119.90141.00132.62474.94542.44398.87
Interest 29.9018.5010.99101.80136.20128.96
Gross Profit90.00122.50121.63373.14406.24269.91
Depreciation48.3043.2036.9199.97107.4086.48
Profit Before Tax41.7079.3084.72273.17298.84183.43
Tax6.8013.8014.2845.4426.1331.08
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax3.3015.60-10.0513.25-48.434.72
Reported Net Profit31.6049.9080.49214.48321.14147.63
Extraordinary Items -0.760.250.02-0.19-4.92-4.47
Adjusted Net Profit32.3649.6580.47214.67326.06152.10
Adjst. below Net Profit 0.00-0.700.81-212.82-3.49-9.46
P & L Balance brought forward1123.601154.001152.371153.26986.93951.70
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 79.6079.6079.640.00151.32102.95
P & L Balance carried down1075.601123.601154.031154.921153.26986.93
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %500.00500.00500.00500.00500.00450.00
Earnings Per Share-Unit Curr1.993.145.0513.4620.169.27
Earnings Per Share(Adj)-Unit Curr1.993.145.0513.4617.498.04
Book Value-Unit Curr149.34151.86153.1180.51163.67146.91